Safety, Pharmacokinetics, and Mosquito‐Lethal Effects of Ivermectin in Combination With Dihydroartemisinin‐Piperaquine and Primaquine in Healthy Adult Thai Subjects
Mass administration of antimalarial drugs and ivermectin are being considered as potential accelerators of malaria elimination. The safety, tolerability, pharmacokinetics, and mosquito‐lethal effects of combinations of ivermectin, dihydroartemisinin‐piperaquine, and primaquine were evaluated. Coadmi...
Saved in:
Published in | Clinical pharmacology and therapeutics Vol. 107; no. 5; pp. 1221 - 1230 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.05.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Mass administration of antimalarial drugs and ivermectin are being considered as potential accelerators of malaria elimination. The safety, tolerability, pharmacokinetics, and mosquito‐lethal effects of combinations of ivermectin, dihydroartemisinin‐piperaquine, and primaquine were evaluated. Coadministration of ivermectin and dihydroartemisinin‐piperaquine resulted in increased ivermectin concentrations with corresponding increases in mosquito‐lethal effect across all subjects. Exposure to piperaquine was also increased when coadministered with ivermectin, but electrocardiograph QT‐interval prolongation was not increased. One subject had transiently impaired liver function. Ivermectin mosquito‐lethal effect was greater than predicted previously against the major Southeast Asian malaria vectors. Both Anopheles dirus and Anopheles minimus mosquito mortality was increased substantially (20‐fold and 35‐fold increase, respectively) when feeding on volunteer blood after ivermectin administration compared with in vitro ivermectin‐spiked blood. This suggests the presence of ivermectin metabolites that impart mosquito‐lethal effects. Further studies of this combined approach to accelerate malaria elimination are warranted. |
---|---|
AbstractList | Mass administration of antimalarial drugs and ivermectin are being considered as potential accelerators of malaria elimination. The safety, tolerability, pharmacokinetics, and mosquito-lethal effects of combinations of ivermectin, dihydroartemisinin-piperaquine, and primaquine were evaluated. Coadministration of ivermectin and dihydroartemisinin-piperaquine resulted in increased ivermectin concentrations with corresponding increases in mosquito-lethal effect across all subjects. Exposure to piperaquine was also increased when coadministered with ivermectin, but electrocardiograph QT-interval prolongation was not increased. One subject had transiently impaired liver function. Ivermectin mosquito-lethal effect was greater than predicted previously against the major Southeast Asian malaria vectors. Both Anopheles dirus and Anopheles minimus mosquito mortality was increased substantially (20-fold and 35-fold increase, respectively) when feeding on volunteer blood after ivermectin administration compared with in vitro ivermectin-spiked blood. This suggests the presence of ivermectin metabolites that impart mosquito-lethal effects. Further studies of this combined approach to accelerate malaria elimination are warranted. |
Author | Davidson, Silas A. Kobylinski, Kevin C. White, Nicholas J. Hoglund, Richard M. Pukrittayakamee, Sasithon Winterberg, Markus Pluijm, Rob W. Pantuwatana, Kanchana Hanboonkunupakarn, Borimas Jittamala, Podjanee Dondorp, Arjen Mukaka, Mavuto Day, Nicholas P.J. Phasomkusolsil, Siriporn Tarning, Joel |
Author_xml | – sequence: 1 givenname: Kevin C. surname: Kobylinski fullname: Kobylinski, Kevin C. email: kobylinskikevin@yahoo.com organization: Walter Reed Army Institute of Research – sequence: 2 givenname: Podjanee surname: Jittamala fullname: Jittamala, Podjanee organization: Mahidol University – sequence: 3 givenname: Borimas surname: Hanboonkunupakarn fullname: Hanboonkunupakarn, Borimas organization: Mahidol University – sequence: 4 givenname: Sasithon surname: Pukrittayakamee fullname: Pukrittayakamee, Sasithon organization: Dusit – sequence: 5 givenname: Kanchana surname: Pantuwatana fullname: Pantuwatana, Kanchana organization: Armed Forces Research Institute of Medical Sciences – sequence: 6 givenname: Siriporn surname: Phasomkusolsil fullname: Phasomkusolsil, Siriporn organization: Armed Forces Research Institute of Medical Sciences – sequence: 7 givenname: Silas A. surname: Davidson fullname: Davidson, Silas A. organization: Walter Reed Army Institute of Research – sequence: 8 givenname: Markus surname: Winterberg fullname: Winterberg, Markus organization: University of Oxford – sequence: 9 givenname: Richard M. surname: Hoglund fullname: Hoglund, Richard M. organization: University of Oxford – sequence: 10 givenname: Mavuto surname: Mukaka fullname: Mukaka, Mavuto organization: University of Oxford – sequence: 11 givenname: Rob W. surname: Pluijm fullname: Pluijm, Rob W. organization: University of Oxford – sequence: 12 givenname: Arjen surname: Dondorp fullname: Dondorp, Arjen organization: University of Oxford – sequence: 13 givenname: Nicholas P.J. surname: Day fullname: Day, Nicholas P.J. organization: University of Oxford – sequence: 14 givenname: Nicholas J. surname: White fullname: White, Nicholas J. organization: University of Oxford – sequence: 15 givenname: Joel surname: Tarning fullname: Tarning, Joel organization: University of Oxford |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31697848$$D View this record in MEDLINE/PubMed |
BookMark | eNo9UW1KxDAUDKLo7ip4AskBrCZNm01_yrrqwooLu-LPkqQvNNqmtc0q_ecRPIbn8iS2fsGDYXjDzOPNGO26ygFCx5ScUULCc137MzqlfAeNaMzCgMcs3kUjQkgSJCHjB2jcto89jRIh9tEBozyZikiM0MdaGvDdKV7lsimlrp6sA291e4qly_Bt1T5vra8-396X4HNZ4LkxoH2LK4MXL9CUPbEO9zOrSmWd9LZy-MH6HF_avMuaSjYeSttaZ13vsrI1NLL3dPAdsGps-Ut7jxuQhc87fJFtC483ubR4vVWPQ-Ah2jOyaOHoFyfo_mq-md0Ey7vrxexiGeiIEh4wYWLGk8gwlTAhFQlZAqC1zATnJKbakFhLBWCEUFOWhUJkdKq5MiqLpQzZBJ38-NZbVUKW1sOBTZf-vawXBD-CV1tA97-nJB2qSPsq0qGKdLbaDMi-AJA3g5c |
CitedBy_id | crossref_primary_10_1186_s12936_023_04685_1 crossref_primary_10_2139_ssrn_3706347 crossref_primary_10_1128_aac_00181_24 crossref_primary_10_1136_bmjopen_2023_072347 crossref_primary_10_1128_aac_01730_22 crossref_primary_10_1186_s13071_021_04675_9 crossref_primary_10_1016_j_jmsacl_2023_12_004 crossref_primary_10_1186_s12936_023_04624_0 crossref_primary_10_1126_scitranslmed_abe1535 crossref_primary_10_1128_aac_01272_23 crossref_primary_10_1021_acs_jmedchem_4c01606 crossref_primary_10_1038_s41467_022_30267_x crossref_primary_10_2139_ssrn_3636557 crossref_primary_10_1038_s41598_023_34719_2 crossref_primary_10_1002_cpt_3471 crossref_primary_10_7554_eLife_83201 crossref_primary_10_1002_prp2_712 crossref_primary_10_2174_1567201819666220516163242 crossref_primary_10_1371_journal_pntd_0009144 crossref_primary_10_2196_20904 crossref_primary_10_12688_wellcomeopenres_20613_2 crossref_primary_10_12688_wellcomeopenres_20613_1 crossref_primary_10_1016_S1473_3099_24_00580_2 crossref_primary_10_1002_jcph_2073 crossref_primary_10_1038_s41598_024_81743_x crossref_primary_10_1021_acs_jmedchem_1c00498 crossref_primary_10_1186_s13071_021_04870_8 crossref_primary_10_1186_s13071_022_05557_4 crossref_primary_10_1002_psp4_13233 crossref_primary_10_3390_ph13080196 crossref_primary_10_1128_AAC_00741_20 crossref_primary_10_1111_mve_12788 crossref_primary_10_1016_j_ijid_2024_107236 |
ContentType | Journal Article |
Copyright | 2019 The Authors. published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics. 2019 The Authors. Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics. |
Copyright_xml | – notice: 2019 The Authors. published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics. – notice: 2019 The Authors. Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics. |
DBID | 24P CGR CUY CVF ECM EIF NPM |
DOI | 10.1002/cpt.1716 |
DatabaseName | Wiley Online Library Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1532-6535 |
EndPage | 1230 |
ExternalDocumentID | 31697848 CPT1716 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Thailand |
GeographicLocations_xml | – name: Thailand |
GrantInformation_xml | – fundername: Bill & Melinda Gates Foundation funderid: OPP1134284 – fundername: Wellcome Trust – fundername: Department for International Development |
GroupedDBID | --- --K -Q- .55 .GJ 0R~ 1B1 1CY 1OB 1OC 24P 29B 33P 354 36B 39C 3O- 4.4 52O 53G 5GY 5RE 6J9 70F 8F7 AAESR AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AAQOH AAQQT AAWTL AAYCA AAYOK AAZKR ABCUV ABJNI ABLJU ABQWH ACBNA ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACPOU ACRPL ACXQS ACYXJ ADBBV ADBTR ADKYN ADNMO ADXAS ADZCM ADZMN ADZOD AEEZP AEGXH AEIGN AENEX AEQDE AEUYR AFBPY AFFNX AFFPM AHBTC AI. AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMYDB ASPBG AVWKF AZFZN AZVAB BDRZF BFHJK BMXJE BRXPI C45 CAG COF CS3 DCZOG DPXWK DU5 EBS EE. EJD EMOBN F5P GODZA GWYGA HGLYW IH2 IHE J5H L7B LATKE LEEKS LITHE LOXES LSO LUTES LYRES M41 MEWTI N4W N9A NQ- O9- OPC OVD P2P P2W PALCI RIG RIWAO RJQFR RNTTT ROL RPZ SAMSI SEW SJN SUPJJ TEORI TWZ UHS VH1 WBKPD WH7 WOHZO WXSBR WYJ X7M Y6R YCJ YFH YOC YXB ZGI ZXP ZZTAW CGR CUY CVF ECM EIF NPM PKN |
ID | FETCH-LOGICAL-c4106-38f53694f3b938ab0239eeccad866051cf05cabeef88b73d288d17c6bfbd5aa23 |
IEDL.DBID | 24P |
ISSN | 0009-9236 |
IngestDate | Wed Feb 19 02:28:28 EST 2025 Wed Jan 22 16:35:49 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | Attribution-NonCommercial 2019 The Authors. Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4106-38f53694f3b938ab0239eeccad866051cf05cabeef88b73d288d17c6bfbd5aa23 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcpt.1716 |
PMID | 31697848 |
PageCount | 10 |
ParticipantIDs | pubmed_primary_31697848 wiley_primary_10_1002_cpt_1716_CPT1716 |
PublicationCentury | 2000 |
PublicationDate | May 2020 |
PublicationDateYYYYMMDD | 2020-05-01 |
PublicationDate_xml | – month: 05 year: 2020 text: May 2020 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Clinical pharmacology and therapeutics |
PublicationTitleAlternate | Clin Pharmacol Ther |
PublicationYear | 2020 |
References | 1998; 28 2017; 2 2014; 91 2018; 105 2015; 30 1996; 50 2019; 16 1996 2008; 862 2018; 67 2011; 16 2012; 56 2012; 11 2016; 15 1987; 18 2018; 69 2015; 152 2018; 18 2018; 17 2018; 391 1968; 38 2015; 60 2002; 42 2010; 116 2017; 17 2013; 12 2017; 16 2016; 43 2011; 42 2014; 58 2014; 13 2005; 10 2008; 876 2014 2019; 393 1994; 50 2014; 6 1969; 134 2006; 100 2012; 42 2010; 9 |
References_xml | – volume: 56 start-page: 1571 year: 2012 end-page: 1577 article-title: Randomized, double‐blind, placebo‐controlled trial of monthly versus bimonthly dihydroartemisinin‐piperaquine chemoprevention in adults at high risk of malaria publication-title: Antimicrob. Agents Chemother. – volume: 42 start-page: 341 year: 2011 end-page: 343 article-title: A case report of ivermectin‐induced prolonged liver dysfunction in an elderly patient with scabies publication-title: Japanese J. Clin. Pharmacol. Therapeut. – volume: 13 start-page: e286 year: 2014 article-title: The challenge of artemisinin resistance can only be met by eliminating malaria across the Greater Mekong subregion publication-title: Malaria J. – volume: 17 start-page: e405 year: 2018 article-title: The dynamic of asymptomatic infections following mass drug administrations with dihydroarteminisin‐piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos publication-title: Malaria J. – volume: 134 start-page: 802 year: 1969 end-page: 819 article-title: Gametocytocidal and sporontocidal effects of primaquine upon two strains of publication-title: Military Med. – volume: 862 start-page: 227 year: 2008 end-page: 236 article-title: Development and validation of a liquid chromatographic‐tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects publication-title: J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. – volume: 15 start-page: e339 year: 2016 article-title: Impact of using artemisinin‐based combination therapy (ACT) in the treatment of uncomplicated malaria from in a non‐endemic zone publication-title: Malaria J. – volume: 16 year: 2019 article-title: The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: a cluster randomised trial publication-title: PLoS Med. – year: 1996 – volume: 9 start-page: e373 year: 2010 article-title: Malaria transmission and vector behaviour in a forested malaria focus in central Vietnam and the implications for vector control publication-title: Malaria J. – volume: 12 start-page: e364 year: 2013 article-title: Entomological determinants of insecticide‐treated bed net effectiveness in Western Myanmar publication-title: Malaria J. – volume: 91 start-page: 655 year: 2014 end-page: 662 article-title: Rationale for the coadministration of albendazole and ivermectin to humans for malaria parasite transmission control publication-title: Am. J. Trop. Med. Hyg. – volume: 152 start-page: 220 year: 2015 end-page: 227 article-title: The relationship between wing length, blood meal volume, and fecundity for seven colonies of species housed at the Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand publication-title: Acta Tropica – volume: 43 start-page: 1030 year: 2016 end-page: 1036 article-title: Effect of high‐fat meal intake on the pharmacokinetic profile of ivermectin in Japanese patients with scabies publication-title: J. Dermatol. – volume: 42 start-page: 1122 year: 2002 end-page: 1133 article-title: Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects publication-title: J. Clin. Pharmacol. – volume: 6 start-page: 260ra147 year: 2014 article-title: Characterization of an in vivo concentration‐effect relationship for piperaquine in malaria chemoprevention publication-title: Science Transl. Med. – volume: 876 start-page: 61 year: 2008 end-page: 68 article-title: A liquid chromatographic‐tandem mass spectrometric method for determination of artesunate and its metabolite dihydroartemisinin in human plasma publication-title: J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. – year: 2014 – volume: 18 start-page: 615 year: 2018 end-page: 626 article-title: Safety and mosquitocidal efficacy of high‐dose ivermectin when co‐administered with dihydroartemisinin‐piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double‐blind, placebo‐controlled trial publication-title: Lancet Infect. Dis. – volume: 105 start-page: 388 year: 2018 end-page: 401 article-title: Pharmacokinetics‐pharmacodynamics of high‐dose ivermectin with dihydroartemisinin‐piperaquine on mosquitocidal activity and QT‐Prolongation (IVERMAL) publication-title: Clin. Pharmacol. Ther. – volume: 69 start-page: 1112 year: 2018 end-page: 1119 article-title: Human direct skin feeding versus membrane feeding to assess the mosquitocidal efficacy of high‐dose ivermectin (IVERMAL Trial) publication-title: Clin. Infect. Dis. – volume: 13 start-page: e417 year: 2014 article-title: Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments publication-title: Malaria J. – volume: 100 start-page: 795 year: 2006 end-page: 797 article-title: First case of ivermectin‐induced severe hepatitis publication-title: Trans. Royal Soc. Trop. Med. Hyg. – volume: 42 start-page: 1088 year: 2012 end-page: 1095 article-title: metabolism of piperaquine is primarily mediated by CYP3A4 publication-title: Xenobiotica – volume: 116 start-page: 119 year: 2010 end-page: 125 article-title: The effect of oral anthelmintics on the survivorship and re‐feeding frequency of anthropophilic mosquito disease vectors publication-title: Acta Tropica – volume: 10 start-page: 251 year: 2005 end-page: 262 article-title: Behavioural heterogeneity of species in ecologically different localities in Southeast Asia: a challenge for vector control publication-title: Trop. Med. Int. Health – volume: 67 start-page: 817 year: 2018 end-page: 826 article-title: A controlled trial of mass drug administration to interrupt transmission of multidrug‐resistant falciparum malaria in Cambodian villages publication-title: Clin. Infect. Dis. – volume: 17 start-page: e15 year: 2017 end-page: e20 article-title: Does antimalarial mass drug administration increase or decrease the risk of resistance? publication-title: Lancet Infect. Dis. – volume: 11 start-page: e418 year: 2012 article-title: Rationale for recommending a lower dose of primaquine as a gametocytocide in populations where G6PD deficiency is common publication-title: Malaria J. – volume: 38 start-page: 625 year: 1968 end-page: 632 article-title: Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine‐resistant strain of publication-title: Bull. World Health Organ. – volume: 28 start-page: 313 year: 1998 end-page: 321 article-title: Identification of cytochrome P4503A4 as the major enzyme responsible for the metabolism of ivermectin by human liver microsomes publication-title: Xenobiotica – volume: 60 start-page: 357 year: 2015 end-page: 365 article-title: Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double‐blind, randomized, clinical trial publication-title: Clin. Infect. Dis. – volume: 16 start-page: e280 year: 2017 article-title: Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion publication-title: Malaria J. – volume: 16 start-page: e474 year: 2017 article-title: Ivermectin susceptibility, sporontocidal effect, and inhibition of time to re‐feed in the Amazonian malaria vector publication-title: Malaria J. – volume: 391 start-page: 1916 year: 2018 end-page: 1926 article-title: Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on malaria in Eastern Myanmar: an observational study of a regional elimination programme publication-title: Lancet – volume: 50 start-page: 646 year: 1994 end-page: 653 article-title: Prevention of sporogony of and in mosquitoes by transmission‐blocking antimalarials publication-title: Am. J. Trop. Med. Hyg. – volume: 30 start-page: 385 year: 2015 end-page: 390 article-title: Mechanism for transport of ivermectin to the stratum corneum in rats publication-title: Drug Metab. Pharmacokinet. – volume: 16 start-page: 608 year: 2011 end-page: 621 article-title: Where would I be without ivermectin? Capturing the benefits of community‐directed treatment with ivermectin in Africa publication-title: Trop. Med. Int. Health – volume: 18 start-page: 289 year: 1987 end-page: 302 article-title: Comparative and metabolism of ivermectin in steers, sheep, swine, and rat publication-title: Drug Metab. Rev. – volume: 2 start-page: e81 year: 2017 article-title: Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin‐resistant falciparum malaria: a pilot trial in four villages of Eastern Myanmar publication-title: Wellcome Open Res. – volume: 15 start-page: e43 year: 2016 article-title: Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim®) in the treatment of uncomplicated malaria at public health facilities in four African countries publication-title: Malaria J. – volume: 15 start-page: e491 year: 2016 article-title: Filling gaps on ivermectin knowledge: effects on the survival and reproduction of , a Latin American malaria vector publication-title: Malaria J. – volume: 50 start-page: 407 year: 1996 end-page: 410 article-title: Ivermectin distribution in the plasma and tissues of patients infected with publication-title: Eur. J. Clin. Pharmacol. – volume: 393 start-page: 1517 year: 2019 end-page: 1526 article-title: Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster‐randomised trial publication-title: Lancet – volume: 58 start-page: 7340 year: 2014 end-page: 7346 article-title: Open‐label crossover study of primaquine and dihydroartemisinin‐piperaquine pharmacokinetics in healthy adult Thai subjects publication-title: Antimicrob. Agents Chemother. |
SSID | ssj0004988 |
Score | 2.4852026 |
Snippet | Mass administration of antimalarial drugs and ivermectin are being considered as potential accelerators of malaria elimination. The safety, tolerability,... |
SourceID | pubmed wiley |
SourceType | Index Database Publisher |
StartPage | 1221 |
SubjectTerms | Adolescent Adult Animals Anopheles - drug effects Antimalarials - administration & dosage Antimalarials - adverse effects Antimalarials - pharmacokinetics Artemisinins - administration & dosage Artemisinins - adverse effects Artemisinins - pharmacokinetics Drug Interactions Drug Therapy, Combination Female Humans Insecticides - administration & dosage Insecticides - adverse effects Insecticides - pharmacokinetics Ivermectin - administration & dosage Ivermectin - adverse effects Ivermectin - pharmacokinetics Malaria - prevention & control Male Middle Aged Primaquine - administration & dosage Primaquine - adverse effects Primaquine - pharmacokinetics Quinolines - administration & dosage Quinolines - adverse effects Quinolines - pharmacokinetics Thailand Young Adult |
Title | Safety, Pharmacokinetics, and Mosquito‐Lethal Effects of Ivermectin in Combination With Dihydroartemisinin‐Piperaquine and Primaquine in Healthy Adult Thai Subjects |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcpt.1716 https://www.ncbi.nlm.nih.gov/pubmed/31697848 |
Volume | 107 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NTtwwELYKvXBB0Jb_Vj5UeyIisROvfUS0qy1iUaQuglvkX-0KNbsl4bA3HoHH4Ln6JJ2Jd1mOSFGiJI7taOzxjDXfN4R8ZyGDVb7QSRA6TXCPIVFShoQHaUNfuTxjiEYeXYvhTX55V9wtoyoRCxP5IV433HBmdPoaJ7g2zdmaNNTOMaFuJjbIR0TWIm8-y8s1JlJJucqiBkaMWBHPpuxs9eWbReetYdqtLIMdsr00Cel5lOEu-eDrT6RXRk7pxSkdryFSzSnt0XLNNr34TF5-6-BbKLZ6fA9_Fovq2tHRrPn7CLP239PzlW8n0E7kK27oLNBfMI7_oMarKRygGsBN7iRFb6fthP6YThbuYYZRnzAaMJME1FJO59AdqLP2XQMl0lXEW6gjopoW9BxpPaDnekpBNeFeT_OF3Ax-ji-GyTL9QmLzDCPiZCi4UHngRnGpDcJgPUrcSQFOUGZDWlhtvA9Smj53TEqX9a0wwbhCa8b3yGY9q_0BoQZ0rkqDtSI1uVdcSZM6z1LuLVfW2UOyHyVRzSPHRsUzAf5tLg9JrxPN64tIs8wqEGKFQqwuyjFej95b8JhsMfSZu6DFE7LZPjz6r2BYtOZbN4LgfF2O_gN7ONF3 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NTtwwELYoHNoLKpS20NL6UO2JiMROvLY4IVq0wC6KxKJyi_yrXVVkFzYc9tZH6GPwXH2SzsSE5VgpUpTEsRN9nvHMyPMNId9YyGCVL3QShE4TjDEkSsqQ8CBt6CuXZwyzkUeXYnCdn98UN2vkqMuFifwQzwE3lIxWX6OAY0D6cMUaaudYUTcTr8hGLlgfpZLl5SopUknZlVEDK0Z0zLMpO-zefLHqvLRM26Xl9C3ZfLIJ6XEEcYus-Xqb9MpIKr08oONVjtTigPZouaKbXr4jj1c6-Aaadbd_wa_Fprp2dDRb3D2A2P79_WfomwmMEwmLF3QW6BlM5FtUeTWFA3QD-MktVPTntJnQ79PJ0t3PcNsnTAcsJQG9lNM5fA70Wft2gBL5KuIl9BHTmpb0GHk94Mv1lIJuwmDPYodcn_4YnwySp_oLic0z3BInQ8GFygM3ikttMA_WI-ROCvCCMhvSwmrjfZDS9LljUrqsb4UJxhVaM_6erNez2n8k1IDSVWmwVqQm94oraVLnWcq95co6u0s-RCSqeSTZqHgmwMHN5S7ptdA8P4g8y6wCECsEsTopx3je-9-GX8nrwXg0rIZnlxefyBuGDnS7g_EzWW_uH_w-WBmN-dLOpn_WctPX |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NTtwwELb4kSouVYEC2xbqA9oTEUmceO0jgq6WsosidVG5Rf7VrhDZLRsOe-sj9DH6XDwJM_H-cESKFCVxbEefPZ5xZr4h5DT1CazyuYo8V3GEewyRFMJHzAvjO9JmSYrRyINb3rvLft7n9wuvSoyFCfwQqw03nBmNvMYJPrX-fE0aaqaYUDfhm2S7-deHrM5ZsY6JlEIss6iBEsOXxLNxer58882i81YxbVaW7ifycaES0ouA4S7ZcNUeaReBU3p-RofrEKnZGW3TYs02Pd8n_38p72ootrz9AF8WiqrK0sFk9ucZZu3L3399V4-gncBXPKMTT69hHD-ixKsoHCAawExukKK_x_WIXo1Hc_s0Qa9PGA2YSQJqKcZT6A7UWbmmgQLpKsIl1BGimub0Amk9oOdqTEE04V7P7DO56_4YXvaiRfqFyGQJesQJnzMuM8-0ZEJpDIN1iLgVHIygxPg4N0o754XQHWZTIWzSMVx7bXOlUnZAtqpJ5Y4I1SBzZeyN4bHOnGRS6Ni6NGbOMGmsaZHDgEQ5DRwbJUs42LeZaJF2A83qQaBZTksAsUQQy8tiiOcv7y34nXworrpl__r25ivZSdF8bvwXv5Gt-unZHYOOUeuTZjC9Assv0wk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Safety%2C+Pharmacokinetics%2C+and+Mosquito%E2%80%90Lethal+Effects+of+Ivermectin+in+Combination+With+Dihydroartemisinin%E2%80%90Piperaquine+and+Primaquine+in+Healthy+Adult+Thai+Subjects&rft.jtitle=Clinical+pharmacology+and+therapeutics&rft.au=Kobylinski%2C+Kevin+C.&rft.au=Jittamala%2C+Podjanee&rft.au=Hanboonkunupakarn%2C+Borimas&rft.au=Pukrittayakamee%2C+Sasithon&rft.date=2020-05-01&rft.issn=0009-9236&rft.eissn=1532-6535&rft.volume=107&rft.issue=5&rft.spage=1221&rft.epage=1230&rft_id=info:doi/10.1002%2Fcpt.1716&rft.externalDBID=10.1002%252Fcpt.1716&rft.externalDocID=CPT1716 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-9236&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-9236&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-9236&client=summon |